Rating History for Atrium Therapeutics (RNA) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for RNA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/22/2026 Boobalan Pachaiyappan New Coverage Buy
(N/A)		 15.00
(N/A)		 7.98
(8.17)		 2.38% Details